Welcome to our dedicated page for Commvault Sys SEC filings (Ticker: CVLT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Commvault Systems, Inc. (NASDAQ: CVLT) SEC filings page provides access to the company’s official disclosures filed with the U.S. Securities and Exchange Commission. As a data processing and hosting company focused on data management and unified cyber resilience, Commvault uses these filings to report on financial results, governance decisions, and material corporate events.
Investors can review Form 8-K current reports in which Commvault announces items such as quarterly earnings press releases, outcomes of its annual meeting of stockholders, and significant financing transactions. For example, recent 8-K filings describe the issuance of 0% Convertible Senior Notes due 2030 under an indenture, along with related capped call transactions, and provide details on voting results for director elections, advisory votes on executive compensation, auditor ratification, and additional shares under the company’s omnibus incentive plan.
Commvault’s proxy statement (DEF 14A) offers further insight into board composition, committee structure, risk and cybersecurity oversight, stockholder engagement, and executive compensation programs. Annual and quarterly reports on Forms 10-K and 10-Q, when accessed, give a broader view of the company’s business, risk factors, and financial condition over time.
On Stock Titan, these filings are paired with AI-powered summaries that help explain key terms and sections, making complex documents such as 10-Ks, 10-Qs, and 8-Ks easier to understand. Users can also monitor insider transaction reports on Form 4, along with other relevant forms, to follow equity awards and trading activity by officers and directors. Real-time updates from EDGAR combined with AI-driven highlights allow investors, analysts, and researchers to quickly identify the most important information in Commvault’s regulatory record.
Form 144 notice for Commvault Systems, Inc. (CVLT). The filing shows a proposed sale of 4,621 common shares through Morgan Stanley Smith Barney on NASDAQ with an aggregate market value of $820,389.70 and an approximate sale date of 08/18/2025. The filer acquired 2,505 performance shares on 08/16/2024 and 2,116 on 08/15/2024. The document also lists multiple insider sales by Sanjay Mirchandani in May 2025 totaling 57,392 shares across several transactions with gross proceeds shown for each sale.
Form 144 notice for Commvault Systems, Inc. (CVLT): This filing notifies the proposed sale of 6,614 shares of Common stock through Morgan Stanley Smith Barney on NASDAQ, with an aggregate market value of $1,190,652.28 and approximately 44,513,830 shares outstanding. The securities to be sold include Restricted Stock (10,280 shares) and Performance Stock (6,523 shares) acquired from the issuer on 08/15/2025, with payment dated 08/15/2025. The filer has reported multiple recent open-market Common stock sales during May 2025 totaling 94,664 shares generating gross proceeds shown per transaction. The notice includes the filer’s representation that they have no undisclosed material adverse information.
Commodult Systems, Inc. (CVLT) filed a Form 144 reporting a proposed sale of common stock. The notice shows 11,035 shares to be sold through Morgan Stanley Smith Barney, LLC with an aggregate market value of $1,986,520.70, and cites approximately 44,513,830 shares outstanding. The proposed sale date is 08/18/2025. The filing discloses that the securities were acquired on 08/15/2025 as restricted stock (17,446 shares) and performance stock (8,614 shares). The filer reports no securities sold in the past three months and includes the standard signature representation about material nonpublic information.
Form 144 notice for Commvault Systems, Inc. (CVLT) reporting proposed sale of 2,594 common shares through Morgan Stanley Smith Barney on 08/18/2025 with an aggregate market value of $466,971.88. The filing lists acquisition entries showing the filer acquired 3,505 restricted shares and 2,243 performance shares on 08/15/2025 from the issuer, with payment noted as not applicable. The filing also discloses multiple open-market sales by Gary Merrill during May 2025 totaling 36,827 shares and gross proceeds of $6,539,565.26. The filer certifies no undisclosed material adverse information.
Sanders A. Shane, a director of Commvault Systems, Inc. (CVLT), reported a grant of 1,189 restricted stock units (RSUs) on 08/07/2025. The RSUs are recorded as common stock and will vest 100% on the later of the one-year anniversary of the grant or the date of the 2026 Annual Meeting of Shareholders; the filing shows his beneficial ownership at 8,023 shares prior to the sale.
On 08/11/2025 Mr. Shane sold 612 shares at $182.92. The sale was effected pursuant to an existing Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. After the reported transactions his direct beneficial ownership is shown as 7,411 shares. The Form 4 was executed on 08/11/2025 by an attorney-in-fact, Danielle Abrahamsen.
Commvault director Vivie Lee received 1,189 restricted stock units that vest 100% on the later of the one-year anniversary of grant or the 2026 Annual Meeting, increasing her reported beneficial ownership to 14,739 shares. The award was reported as a grant with a $0 cash price, reflecting typical equity compensation in the form of restricted stock units.
Subsequently, Lee sold 765 shares at $182.92 per share pursuant to a pre-existing Rule 10b5-1 trading plan adopted February 3, 2025, reducing her beneficial ownership to 13,974 shares. The transactions are routine director compensation and plan-based selling; no derivative transactions or exercisable options are reported.
Allison Pickens, a director of Commvault Systems (CVLT), was granted 1,189 restricted stock units (RSUs) on 08/07/2025. The award is recorded as an acquisition at no cash price and increases her beneficial ownership to 5,856 common shares. The RSUs are subject to a single vesting event: they vest 100% on the later of the one-year anniversary of the grant or the date of the 2026 Annual Meeting of Shareholders.
The grant aligns a board member’s compensation with shareholder value by delivering equity rather than cash and formally appears on a Form 4 insider report as an acquisition of non-derivative securities. The filing was submitted by an attorney-in-fact on behalf of the reporting person and includes the required explanatory note on vesting.
The Form 4 shows director Charles E. Moran received a grant of 1,189 restricted stock units (RSUs) in Commvault Systems, Inc. (ticker CVLT) with a transaction date of 08/07/2025. The RSUs were granted at a price of $0 (typical for restricted awards) and are reported as acquired shares.
The filing reports 13,686 shares of common stock beneficially owned by Mr. Moran following the reported transaction, held in a direct ownership form. The award is described as vesting 100% on the later of the one-year anniversary of the grant or the date of the 2026 Annual Meeting of Shareholders.
Adamo Nicola, a director of Commvault Systems (CVLT), was granted 1,189 restricted stock units (RSUs) of common stock on 08/07/2025, issued with no purchase price.
The award increases his direct beneficial ownership to 17,367 shares. The RSUs vest 100% on the later of the one-year anniversary of the grant or the date of the 2026 Annual Meeting of Shareholders, making the grant time‑based and tied to the next shareholder meeting.
Martha Helena Bejar, a director of Commvault Systems Inc. (CVLT), acquired 1,189 restricted stock units (RSUs) on 08/07/2025 as reported on Form 4. The grant is recorded as an acquisition at a $0 price and increases her direct beneficial ownership to 7,036 shares. The RSUs vest 100% on the later of the one‑year anniversary of the grant or the date of the 2026 Annual Meeting of Shareholders.
The filing shows a straightforward equity award to a board member with no derivative instruments reported and documents the post‑grant share count; it does not disclose additional cash compensation, option grants, or other transactions.